S&P 500   3,009.29 (+0.09%)
DOW   26,818.76 (-0.03%)
QQQ   194.09 (+0.36%)
AAPL   240.88 (+0.15%)
FB   189.89 (+0.07%)
MSFT   139.47 (+0.75%)
GOOGL   1,245.41 (+0.09%)
AMZN   1,783.61 (-0.11%)
CGC   20.39 (+0.20%)
NVDA   200.70 (+2.39%)
MU   45.19 (-0.07%)
BABA   174.73 (+0.70%)
GE   8.70 (-1.02%)
TSLA   253.40 (-0.04%)
AMD   31.77 (-0.81%)
T   37.64 (-1.54%)
F   9.00 (-0.44%)
ACB   3.64 (-1.35%)
PRI   125.69 (+0.00%)
NFLX   271.11 (-2.50%)
BAC   30.79 (-0.74%)
GILD   65.83 (+0.95%)
DIS   132.75 (+1.91%)
S&P 500   3,009.29 (+0.09%)
DOW   26,818.76 (-0.03%)
QQQ   194.09 (+0.36%)
AAPL   240.88 (+0.15%)
FB   189.89 (+0.07%)
MSFT   139.47 (+0.75%)
GOOGL   1,245.41 (+0.09%)
AMZN   1,783.61 (-0.11%)
CGC   20.39 (+0.20%)
NVDA   200.70 (+2.39%)
MU   45.19 (-0.07%)
BABA   174.73 (+0.70%)
GE   8.70 (-1.02%)
TSLA   253.40 (-0.04%)
AMD   31.77 (-0.81%)
T   37.64 (-1.54%)
F   9.00 (-0.44%)
ACB   3.64 (-1.35%)
PRI   125.69 (+0.00%)
NFLX   271.11 (-2.50%)
BAC   30.79 (-0.74%)
GILD   65.83 (+0.95%)
DIS   132.75 (+1.91%)
Log in

KemPharm SEC Filings & 10K Form (NASDAQ:KMPH)

$0.58
+0.02 (+3.57 %)
(As of 10/22/2019 09:42 AM ET)
Today's Range
$0.54
Now: $0.58
$0.60
50-Day Range
$0.57
MA: $0.75
$0.94
52-Week Range
$0.52
Now: $0.58
$3.00
Volume8,700 shs
Average Volume121,235 shs
Market Capitalization$18.30 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

SEC Filings

KemPharm (NASDAQ:KMPH) SEC Filings

DateFilerForm TypeView
10/16/2019
4:25 PM
KemPharm (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2019
4:09 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
7:58 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
7:57 PM
KemPharm (Issuer)
Sangiovanni Timothy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
7:25 PM
KemPharm (Issuer)
Mickle Travis C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
4:07 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
3:59 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:50 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:12 PM
Johnson Gordon K (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
4:06 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
7:01 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
4:17 PM
KemPharm (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2019
4:06 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
12:26 PM
KemPharm (Subject)
Mangless Daniel John (Filed by)
Form SC 13G
05/23/2019
4:21 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
7:39 PM
KemPharm (Issuer)
Pascoe Richard W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:39 PM
KemPharm (Issuer)
Thompson Danny L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:39 PM
KemPharm (Issuer)
Saluri Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:39 PM
KemPharm (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:38 PM
KemPharm (Issuer)
Plooster Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
4:32 PM
KemPharm (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2019
3:10 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:06 PM
KemPharm (Issuer)
Saluri Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
4:05 PM
KemPharm (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
4:02 PM
KemPharm (Issuer)
Pascoe Richard W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
4:01 PM
KemPharm (Issuer)
Thompson Danny L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
4:01 PM
KemPharm (Issuer)
Plooster Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
3:54 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
3:59 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2019
12:21 PM
KemPharm (Filer)
Form CT ORDER
03/15/2019
6:33 AM
KemPharm (Filer)
Form DEFA14A
03/15/2019
6:30 AM
KemPharm (Filer)
Form DEF 14A
03/13/2019
6:38 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
4:28 PM
KemPharm (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/01/2019
4:05 PM
KemPharm (Filer)
Form 424B5
03/01/2019
4:03 PM
KemPharm (Filer)
Form 424B5
03/01/2019
3:54 PM
KemPharm (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2019
3:26 PM
Johnson Gordon K (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:08 PM
Alyeska Investment Group, L.P. (Filed by)
KemPharm (Subject)
Form SC 13G/A
02/11/2019
4:03 PM
KemPharm (Subject)
Mickle Travis C (Filed by)
Form SC 13G/A
02/08/2019
6:29 PM
KemPharm (Issuer)
Mickle Travis C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
6:28 PM
Johnson Gordon K (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
6:28 PM
Guenther Sven (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:36 PM
KemPharm (Issuer)
Sangiovanni Timothy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:36 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
3:05 PM
Delaware Street Capital Master Fund, L.P. (Filed by)
KemPharm (Subject)
Form SC 13G/A
01/07/2019
8:18 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
6:36 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
8:24 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2018
1:36 PM
Flynn James E (Filed by)
KemPharm (Subject)
Form SC 13G/A
11/20/2018
4:17 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
4:16 PM
KemPharm (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:12 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
4:07 PM
KemPharm (Filer)
Form D
Notice of Exempt Offering of Securities 
10/30/2018
3:07 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2018
3:28 PM
KemPharm (Issuer)
Sangiovanni Timothy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2018
3:35 PM
KemPharm (Issuer)
Mickle Travis C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2018
3:12 PM
Johnson Gordon K (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
5:52 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2018
3:01 PM
BLUHM ANDREW G (Reporting)
Delaware Street Capital Master Fund, L.P. (Reporting)
DSC Advisors, L.L.C. (Reporting)
DSC Advisors, L.P. (Reporting)
DSC Managers, L.L.C. (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
4:07 PM
KemPharm (Filer)
Form 424B5
10/05/2018
9:03 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2018
4:27 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2018
4:26 PM
KemPharm (Filer)
Form 424B5
09/17/2018
6:33 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
3:43 PM
KemPharm (Filer)
Form 424B5
09/04/2018
3:39 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2018
4:15 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
3:09 PM
KemPharm (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
3:06 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
7:42 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2018
3:05 PM
BLUHM ANDREW G (Reporting)
Delaware Street Capital Master Fund, L.P. (Reporting)
DSC Advisors, L.L.C. (Reporting)
DSC Advisors, L.P. (Reporting)
DSC Managers, L.L.C. (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2018
6:05 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
3:29 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
3:14 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:06 PM
KemPharm (Issuer)
Saluri Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:06 PM
KemPharm (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:05 PM
KemPharm (Issuer)
Thompson Danny L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:04 PM
KemPharm (Issuer)
Plooster Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:04 PM
KemPharm (Issuer)
Pascoe Richard W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
8:18 PM
Cohen Daniel L (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
3:39 PM
KemPharm (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2018
3:33 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2018
3:33 PM
KemPharm (Filer)
Form DEFA14A
04/12/2018
3:32 PM
KemPharm (Filer)
Form DEF 14A
03/30/2018
4:04 PM
KemPharm (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/30/2018
4:00 PM
KemPharm (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2018
3:18 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2018
4:22 PM
KemPharm (Issuer)
Thompson Danny L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2018
7:28 AM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2018
1:26 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2018
7:33 AM
Flynn James E (Filed by)
KemPharm (Subject)
Form SC 13G/A
02/12/2018
8:18 AM
KemPharm (Subject)
Mickle Travis C (Filed by)
Form SC 13G/A
01/31/2018
4:12 PM
KemPharm (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2018
5:57 PM
KemPharm (Issuer)
Sangiovanni Timothy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
5:56 PM
Guenther Sven (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
5:56 PM
Cohen Daniel L (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
5:56 PM
Johnson Gordon K (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
5:56 PM
Clifton R. LaDuane (Reporting)
KemPharm (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
5:56 PM
KemPharm (Issuer)
Mickle Travis C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel